Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

India's billionaire Poonawalla family pledges $66 million to Oxford University

Published 15/12/2021, 00:05
Updated 15/12/2021, 00:35
© Reuters. FILE PHOTO: Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas/File Photo

© Reuters. FILE PHOTO: Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas/File Photo

(Reuters) - Vaccine maker Serum Institute of India (SII) has pledged 50 million pounds ($66.2 million) to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot.

The investment was made through the Indian company's Serum Life Sciences unit, Oxford University said on Wednesday. The research building would be named after Serum's billionaire owners, the Poonawalla family. The pledge builds on the collaboration between Oxford University, AstraZeneca (NASDAQ:AZN) and SII, the world's largest maker of vaccines and the producer of a version of the British duo's COVID-19 shot for low- and middle-income countries.

SII has also agreed with the Jenner Institute, which was behind the Oxford-AstraZeneca COVID-19 vaccine, to produce and develop Jenner's R21/Matrix-M malaria shot on a large scale. The shot is currently in late-stage trials.

SII was founded in 1966 in the Western Indian city of Pune by Cyrus Poonawalla, son of a horse breeder, and India's fifth-richest person, according to Forbes. In 2019, Cyrus was also conferred an honorary degree by Oxford University.

It is currently run by his son Adar Poonawalla, whose wife Natasha Poonawalla heads Serum Life Sciences. With a penchant for luxury cars and racehorses, the pair is often seen rubbing shoulders with Hollywood and Bollywood stars.

© Reuters. FILE PHOTO: Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas/File Photo

The Poonawallas in September invested 50 million pounds in Oxford Biomedica to help fund the development of a plant that manufactures COVID-19 shots.

($1 = 0.7559 pounds)

Latest comments

Let me guess, your future family generations will get guaranteed access to study at Oxford Uni also…right??-
Does it matter when so many will benefit
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.